$DRMA
Dermata Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.07
▼-4.46%-$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateDermata Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DRMA down today? It is at $1.07 (-4.46%). See the catalyst behind the move, real-time alerts the moment DRMA spikes, and full due diligence on DRMA — key stats, earnings, dilution and insider activity. Free.
Be first to know when $DRMA makes an unusual move. Create a free account to track $DRMA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DRMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DRMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Across every filing on file, supply equal to 5886.1% of the tradeable float is in play - 5886.1% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Van Hoose Kyri K. Officer | Acquired (grant/award) | +102K 2.5% of company | added 78% | 232K | n/a | Aug 16, 26 |
Proehl Gerald T Officer | Acquired (grant/award) | +170K 4.2% of company | added 84% | 373K | n/a | Aug 16, 26 |
Scott Kathleen D. Director | Sold (automatic/other) | -11 | n/a | n/a | $13 at $1.19 | Jun 16, 26 |
Bedoya-Toro Munera Maria E Officer | Bought (open market) | +1K 0.02% of company | added 100% | 1K | $1K at $1.27 | Feb 17, 26 |
Proehl Gerald T Officer | Acquired (grant/award) | +613K 15.2% of company | added 100% | 693K | n/a | Dec 23, 25 |
Van Hoose Kyri K. Officer | Acquired (grant/award) | +123K 3.0% of company | added 100% | 130K | n/a | Dec 23, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on DRMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DRMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
DRMA last traded at $1.07, down 4.46% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Dermata Therapeutics, Inc. Common Stock (DRMA) is next expected to report earnings on Friday, November 13, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DRMA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DRMA 0 times in the last 30 days.
DRMA (Dermata Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $4M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DRMA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DRMA discussion
Sign in to ask a question or join the discussion.